DBV Technologies is a struggling clinical-stage French biotech in active turnaround under CEO Daniel Tassé (since March 2024), with two prior FDA rejections of Viaskin Peanut and a workforce reduced by approximately 70% in 2024.
The company operates two separate careers portals — French for Châtillon HQ and English for Basking Ridge NJ — and applications must be tailored in language, format, and cultural register to the matching geography.
You're here early and that means a lot! ResumeGeni is in Beta which means it isn't 100% finished yet, but every day I'm working towards the vision. It's my goal to help you land your next job.
During the Beta, you'll get access to the state of the art AI to help find your perfect match, and when you do ResumeGeni will prepare your resume to get you to the interview.
There's still a lot to do. Please reach out if you have feedback, a request, or just want to send me a note.
